Showing results (441-450 of 528) with videos related to

Sort By:
Pageof 53
Nature Immunology|February 12, 2019
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Statistical Communications in Infectious Diseases|December 9, 2017
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy TrialsPeter B Gilbert, Michal Juraska, Allan C deCamp, et al.
Nature Immunology|April 14, 2019
Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responsesMasaru Kanekiyo, M Gordon Joyce, Rebecca A Gillespie, et al.
Plos One|September 30, 2010
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore, et al.
Lancet (London, England)|January 29, 2019
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 studyMartin R Gaudinski, Emily E Coates, Laura Novik, et al.
Immunity|November 10, 2022
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A virusesSyed M Moin, Jeffrey C Boyington, Seyhan Boyoglu-Barnum, et al.
Cell|November 19, 2022
A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralizationTulika Singh, Kwan-Ki Hwang, Andrew S Miller, et al.
Cell Reports|December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Iscience|February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer baseHongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Pageof 53